CPChandrasekar Palanichamy

Chandrasekar Palanichamy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chandrasekar Palanichamy has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Mimosa pudica Linn. Root Extract-Mediated Synthesis of Zinc Oxide Nanoparticles: a Study of Glucose Uptake Efficiency on 3T3-L1 Adipocytes

    by Chandrasekar Palanichamy, Pavadai Parasuraman, Panneerselvam Theivendren, Murugesan Sankaranarayanan, Madasamy Sundar, Selvaraj Kunjiappan


  • Optimization of ultrasound-assisted extraction of bioactive chemicals from Hemidesmus indicus (L.) R.Br. using response surface methodology and adaptive neuro-fuzzy inference system

    by Senthilkumar Vellur, Parasuraman Pavadai, Sureshbabu Ram Kumar Pandian, Chandrasekar Palanichamy, Shanmugampillai Jeyarajaguru Kabilan, Krishnan Sundar, Suthendran Kannan, Selvaraj Kunjiappan

    This study was designed to optimize the ultrasound-assisted extraction (UAE) of bioactive chemicals from Hemidesmus indicus (L.) R.Br. through RSM (response surface methodology) and ANFIS (adaptive neuro-fuzzy inference system). The effect of four independent parameters, methanol concentration (X1: 55–65%), temperature (X2: 30–40 °C), time (X3: 15–20 min) and particle size (X4: 0.5–1.00 mm) at five levels (− 2 ,− 1, 0, + 1, + 2) with respect to dependent parameters, total polyphenols content (TP) (y1), total flavonoids content (TF) (y2), %DPPHsc (y3), %ABTSsc (y4) and %H2O2sc (y5) were selected. The optimal extraction condition was observed at X1 = 65%, X2 = 40 °C, X3 = 20 min and X4 = 0.5 mm; under this circumstance, y1 = 352.85 mg gallic acid equivalents (GA)/g, y2 = 300.204 mg rutin equivalents (RU)/g and their antioxidant potentials (y3 = 81.33%, y4 = 65.04%, and y5 = 71.01%) has been attained. ANFIS was used to compare and confirm the optimized extraction parameter values. Further, GC–MS and LC–MS were performed to investigate the bioactive chemicals present in the optimized extract.


  • Open Access

    Aphrodisiac Performance of Bioactive Compounds from Mimosa pudica Linn.: In Silico Molecular Docking and Dynamics Simulation Approach

    by Chandrasekar Palanichamy, Parasuraman Pavadai, Theivendren Panneerselvam, Sankarganesh Arunachalam, Ewa Babkiewicz, Sureshbabu Ram Kumar Pandian, Kabilan Shanmugampillai Jeyarajaguru, Damodar Nayak Ammunje, Suthendran Kannan, Jaikanth Chandrasekaran, et al.

    Plants and their derived molecules have been traditionally used to manage numerous pathological complications, including male erectile dysfunction (ED). Mimosa pudica Linn. commonly referred to as the touch-me-not plant, and its extract are important sources of new lead molecules in drug discovery research. The main goal of this study was to predict highly effective molecules from M. pudica Linn. for reaching and maintaining penile erection before and during sexual intercourse through in silico molecular docking and dynamics simulation tools. A total of 28 bioactive molecules were identified from this target plant through public repositories, and their chemical structures were drawn using Chemsketch software. Graph theoretical network principles were applied to identify the ideal target (phosphodiesterase type 5) and rebuild the network to visualize the responsible signaling genes, proteins, and enzymes. The 28 identified bioactive molecules were docked against the phosphodiesterase type 5 (PDE5) enzyme and compared with the standard PDE5 inhibitor (sildenafil). Pharmacokinetics (ADME), toxicity, and several physicochemical properties of bioactive molecules were assessed to confirm their drug-likeness property. Molecular dynamics (MD) simulation modeling was performed to investigate the stability of PDE5–ligand complexes. Four bioactive molecules (Bufadienolide (−12.30 kcal mol−1), Stigmasterol (−11.40 kcal mol−1), Isovitexin (−11.20 kcal mol−1), and Apigetrin (−11.20 kcal mol−1)) showed the top binding affinities with the PDE5 enzyme, much more powerful than the standard PDE5 inhibitor (−9.80 kcal mol−1). The four top binding bioactive molecules were further validated for a stable binding affinity with the PDE5 enzyme and conformation during the MD simulation period as compared to the apoprotein and standard PDE5 inhibitor complexes. Further, the four top binding bioactive molecules demonstrated significant drug-likeness characteristics with lower toxicity profiles. According to the findings, the four top binding molecules may be used as potent and safe PDE5 inhibitors and could potentially be used in the treatment of ED.